Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
This stack combines a GLP-1 receptor agonist for appetite and insulin signaling with AOD-9604, a growth hormone fragment that specifically targets lipolysis without the broader GH effects. The protocol wizard suggests choosing one GLP agonist (Semaglutide or Tirzepatide) based on your research goals, then adding AOD-9604 as the complementary fat-metabolism compound.
Semaglutide is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes (Ozempic) and chronic weight management (Wegovy). It has become one of the most widely prescribed medications for obesity due to its significant weight-loss efficacy.
Role: GLP-1 receptor agonist. First-generation incretin for appetite suppression and insulin sensitization. Choose this OR Tirzepatide — they target the same receptor family.
Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). It represents a new class of dual-incretin therapy with superior weight-loss efficacy compared to single-agonist approaches.
Role: Dual GLP-1/GIP agonist. Second-generation with greater efficacy than Semaglutide in head-to-head trials (SURMOUNT). Alternative to Semaglutide, not used alongside it.
AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) originally developed as an anti-obesity agent. It stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full HGH.
Role: HGH fragment 176-191. Targets adipose tissue lipolysis specifically, without the muscle-building or blood-sugar effects of full GH. Stacks well with either GLP agonist.
Use the protocol builder to set doses, frequency, and cycle length. Track your progress with blood work integration.
Start ProtocolFor research purposes only. Not medical advice, diagnosis, or treatment. Consult a licensed provider before making any decisions based on this information.
Cognitive & Nootropic Stack
Neuroprotection, focus, and synaptogenesis